Found: 8
Select item for more details and to access through your institution.
Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16947, doi. 10.3390/ijms242316947
- By:
- Publication type:
- Article
3D collagen migration patterns reveal a SMAD3-dependent and TGF-β1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 6, p. 967, doi. 10.1038/s41416-022-02093-x
- By:
- Publication type:
- Article
Biomimetic quantum dot-labeled B16F10 murine melanoma cells as a tool to monitor early steps of lung metastasis by in vivo imaging.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 6391, doi. 10.2147/IJN.S165565
- By:
- Publication type:
- Article
Lung Micrometastases Display ECM Depletion and Softening While Macrometastases Are 30-Fold Stiffer and Enriched in Fibronectin.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2404, doi. 10.3390/cancers15082404
- By:
- Publication type:
- Article
Mitochondrial Dysfunction and the Glycolytic Switch Induced by Caveolin-1 Phosphorylation Promote Cancer Cell Migration, Invasion, and Metastasis.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2862, doi. 10.3390/cancers14122862
- By:
- Publication type:
- Article
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3782, doi. 10.3390/cancers13153782
- By:
- Publication type:
- Article
AT2 Receptor Mediated Activation of the Tyrosine Phosphatase PTP1B Blocks Caveolin-1 Enhanced Migration, Invasion and Metastasis of Cancer Cells.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1299, doi. 10.3390/cancers11091299
- By:
- Publication type:
- Article
Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
- Published in:
- Cancer Science, 2024, v. 115, n. 5, p. 1505, doi. 10.1111/cas.16141
- By:
- Publication type:
- Article